Li Li

Research Associate

19972018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Li Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Protein-Tyrosine Kinases Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Mutation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Stem cells Chemical Compounds
fms-Like Tyrosine Kinase 3 Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3

Nagai, K., Hou, L., Li, L., Nguyen, B., Seale, T., Shirley, C., Ma, H., Levis, M. J., Ghiaur, G., Duffield, A. S. & Small, D., Aug 31 2018, In : Oncotarget. 9, 68, p. 32885-32899 15 p.

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Leukemia
Acute Myeloid Leukemia
Acute Promyelocytic Leukemia
Ubiquitination

Knock-In of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice

Annesley, C. E., Rabik, C., Duffield, A. S., Rau, R. E., Magoon, D., Li, L., Huff, V., Small, D., Loeb, D. M. & Brown, P. A., Oct 1 2018, In : Oncotarget. 9, 82, p. 35313-35326 14 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Wilms Tumor
Mutation
Neoplasms
Karyotype

Adaptation to TKI treatment reactivates ERK signaling in tyrosine kinase–driven leukemias and other malignancies

Bruner, J. K., Ma, H. S., Li, L., Qin, A. C. R., Rudek-Renaut, M., Jones, R. J., Levis, M. J., Pratz, K., Pratilas, C. & Small, D., Oct 15 2017, In : Cancer Research. 77, 20, p. 5554-5563 10 p.

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Tyrosine
Leukemia
Neoplasms
Acute Myeloid Leukemia

FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors

Nguyen, B., Williams, A. B., Young, D. J., Ma, H., Li, L., Levis, M. J., Brown, P. A. & Small, D., 2017, In : Oncotarget. 8, 7, p. 10931-10944 14 p.

Research output: Contribution to journalArticle

fms-Like Tyrosine Kinase 3
Protein-Tyrosine Kinases
Mutation
Acute Myeloid Leukemia
Cell Proliferation

All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo

Ma, H. S., Greenblatt, S. M., Shirley, C. M., Duffield, A. S., Bruner, J. K., Li, L., Nguyen, B., Jung, E., Aplan, P. D., Ghiaur, G., Jones, R. J. & Small, D., Jun 9 2016, In : Blood. 127, 23, p. 2867-2878 12 p.

Research output: Contribution to journalArticle

Tretinoin
Stem cells
Protein-Tyrosine Kinases
Leukemia
Stem Cells